id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2017-N-6312-0001,FDA,FDA-2017-N-6312,Patient-Focused Drug Development: Developing and Submitting Proposed Draft Guidance Relating to Patient Experience Data; Public Workshop; Request for Comments,Notice,Request for Comments,2017-12-14T05:00:00Z,2017,12,2017-12-14T05:00:00Z,2018-05-19T03:59:59Z,2018-04-10T01:05:05Z,2017-26978,0,0,0900006482d08e7c